Compared to adjacent normal tissue, LILRB2 expression was significantly elevated in NSCLC tumor tissue 222-224, 327, and associated with adverse clinicopathological features including poor differentiation, regional LN metastasis, advanced tumor stage, older age, reduced tumor-infiltrating lymphocytes (TILs), and poorer prognosis 222-224, 327-329. This evidence concerns the gene LILRB2 and neoplasm.